- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06631144
A Spanish-language Caregiver-Enabled Care Program (CECP)
Improving Health Equities for Hispanic/Latino Families Living With Dementia by Validating a Spanish-language Caregiver-Enabled Care Program (CECP) in PACE Participants
Study Overview
Status
Intervention / Treatment
Detailed Description
For Hispanic/Latino families in the United States (U.S.), care for a loved one with dementia is provided largely by family caregivers. Evidence-based resources that support and engage family caregivers are critical to improving care and outcomes for persons living with dementia and improving the wellness of their family caregiver. However, access to these vital resources is limited for Hispanic/Latino families in the U.S. To address health disparities in dementia care for Hispanic/Latino families in the U.S., the investigators are developing an approach for deploying the proven Caregiver-Enabled Care Program (CECP) to Spanish-speaking caregivers of patients with dementia. For this study, the investigators will enroll 135 Spanish-speaking family caregiver/dementia-patient dyads living in the U.S. who are participants in a Program for All-Inclusive Care for the Elderly (PACE) or dementia support network or provider. Participation for each caregiver enrolled in the study involves engaging in the Spanish-language CECP for 6 months. The overall duration of the research project is 12 months.
At the conclusion of the study, the investigators expect to show that the highly- scalable approach using Artificial Intelligence (AI) plus human validation provides a Spanish-language CECP that can achieve comparable engagement of the proven English-language CECP. The investigators will measure differences in how Spanish-speaking caregivers engage in education, coaching, and assessments compared to the engagement of English-speaking caregivers. Understanding these differences will allow the investigators to explore potential cultural differences in user engagement and inform future optimization of the program. This Phase 1 Small Business Innovation Research (SBIR) study is supported by the National Institute On Aging (NIA) of the National Institutes of Health (NIH) under Award Number R43AG088143.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Carlsbad, California, United States, 92010
- Ceresti Health
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Patient/Caregiver Dyad Inclusion Criteria
Patient Inclusion Criteria:
- Is a participant of a Program of All-Inclusive Care for the Elderly (PACE) or dementia support network or provider in the United States
- Identifies as Hispanic/Latino
- Has a Spanish-speaking familial caregiver (spouse, adult child, other family member, or friend) that is willing and able to participate in all aspects of this study
- Has a diagnosis of dementia
- Consents to participate in study, or has an Authorized Representative that consents
Caregiver Inclusion Criteria:
• Is a Spanish-speaking family caregiver (spouse, adult child, other family member, friend) providing care/support for the person with dementia
- Is an adult aged 18 or older
- Primary language is Spanish. Able to speak, read, and write Spanish
- Consents to participate in the study
Exclusion Criteria:
• Patient plans to disenroll from the PACE program or dementia support network or provider in in less than 6 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Caregiver-Enabled Care Group
Caregiver participants will receive Ceresti's Caregiver-Enabled Care Program.
(CECP) is a 6-month non-medical digital program that promotes the wellness of family caregivers, and increases their knowledge, skills and confidence ("activation") in caring for a loved one with dementia.
CECP delivers personalized health education, access to resources, proactive coaching, personalized support, and remote monitoring via a dedicated tablet that is shipped to the caregiver's home.
|
CECP is a nonmedical digital population health intervention to support and engage family caregivers of persons with dementia.
CECP consists of digital content, including health education videos and tutorials, that is delivered to caregivers on a dedicated tablet based on their specific needs.
Caregivers are supported by a proactive human coach who provides support, access to resources, and performs risk mitigation measures as necessary.
Alerts are shared with providers and/or care management teams via a data hub that makes it easy to track, manage and resolve alerts.
CECP is delivered over a 6-month period via a dedicated tablet that is shipped to the caregiver's home at no cost to the caregiver or person with dementia.
This study's CECP is in Spanish.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Longitudinal Engagement
Time Frame: From the date of enrollment in the program until the last assessment, assessed up to 6 months.
|
Longitudinal Engagement for this study is assessed as the month-to-month continuation rate of Spanish-speaking caregivers enrolled in the CECP.
|
From the date of enrollment in the program until the last assessment, assessed up to 6 months.
|
|
Intensity of Engagement
Time Frame: From the date of enrollment in the program until the last assessment, assessed up to 6 months.
|
Intensity of Engagement for this study is assessed as the average weekly engagement time of enrolled Spanish-speaking caregivers in education, coaching and assessment of the CECP.
|
From the date of enrollment in the program until the last assessment, assessed up to 6 months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Centers for Disease Control and Prevention (CDC) Healthy Days Measure (Spanish version)
Time Frame: From the date of enrollment until the last monthly assessment, assessed every month up to 6 months
|
Centers for Disease Control and Prevention (CDC) Healthy Days Measure evaluates participants' health status over the past 30 days.
For most questions, 0 days indicates the best health status, and 30 days indicates the worst health status.
Higher scores on the Centers for Disease Control and Prevention (CDC) Healthy Days Measure generally indicate worse outcome, reflecting more days of poor physical and mental health.
Additionally, participants identify their major health problem, indicate whether it limits daily living, and specify the level of assistance needed for personal care and routine activities by selecting one response from a provided list.
|
From the date of enrollment until the last monthly assessment, assessed every month up to 6 months
|
|
Caregiver Activation Scale (in Spanish)
Time Frame: From the date of enrollment until the last monthly assessment, assessed every month up to 6 months
|
Custom question developed by Ceresti to measure increase in caregiver knowledge, skills and confidence.
Higher scores on the Caregiver Activation Scale indicate better outcome.
|
From the date of enrollment until the last monthly assessment, assessed every month up to 6 months
|
|
Loneliness Scale (in Spanish)
Time Frame: From From the date of enrollment until the last monthly assessment, assessed every month up to 6 months
|
Custom questions developed by Ceresti to measure feelings of loneliness experienced in the past 30 days.
Higher scores on the Loneliness Scale indicate worse outcome.
|
From From the date of enrollment until the last monthly assessment, assessed every month up to 6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Dirk Soenksen, CEO
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CER-2024-111-001
- 1R43AG088143-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia
-
Benjamin Rose Institute on AgingNational Institute on Aging (NIA)RecruitingMild Dementia | Moderate DementiaUnited States
-
Yaolin PeiNational Institutes of Health (NIH)RecruitingEnd of Life Decision Making | Dementia Caregivers | Advanced DementiaUnited States
-
Benuvia Therapeutics Inc.MandaraNot yet recruiting
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedAlzheimer Dementia | Dementia Alzheimers | CaregiverUnited States
-
Temple UniversityCompletedDementia | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Hebrew SeniorLifeActive, not recruitingAging | Alzheimer Dementia | Presenile Alzheimer DementiaUnited States
-
Temple UniversityCompletedDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
The University of Hong KongNot yet recruiting
-
NYU Langone HealthRecruiting
-
National Tainan Junior College of NursingCompletedCognitive Impairment | Dementia, Mild | Dementia ModerateTaiwan
Clinical Trials on Spanish-language Caregiver-Enabled Care Program (CECP)
-
Florencia SalvarezzaCompleted
-
Taipei Medical UniversityNot yet recruitingCardiovascular Kidney Metabolic SyndromeTaiwan
-
H. Lee Moffitt Cancer Center and Research InstituteAmerican Cancer Society, Inc.Completed
-
Mark WilliamsUniversity of Pennsylvania; University of Illinois at Chicago; Boston Medical... and other collaboratorsCompletedCare TransitionsUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Active, not recruitingStage IV Lung Cancer | Stage III Lung Cancer | Stage II Lung CancerUnited States
-
Parc de Salut MarRecruitingDisability Physical | STROKE | Brain Disease | Hemiplegia and/or Hemiparesis Following Stroke | Rehabilitation Outcome | Cardiovascular Disease AcuteSpain
-
University of SalernoAzienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'AragonaNot yet recruitingHeart Failure | Frail Elderly Syndrome | Prefrail Elderly
-
Emory UniversityNational Institute on Aging (NIA)Recruiting